University of North Carolina at Chapel Hill- CGIBD
Welcome,         Profile    Billing    Logout  
 1 Trial 
3 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Long, Millie D
TOUR, NCT03772145: Tofacitinib Response in Ulcerative Colitis - a Real World Prospective Multi-center Study

Terminated
N/A
103
US
University of North Carolina, Chapel Hill, Pfizer
Ulcerative Colitis
01/23
01/24
ASSIST, NCT05316584: A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy

Active, not recruiting
N/A
123
US
Remote monitoring
University of Maryland, Baltimore, University of North Carolina, Chapel Hill, Vanderbilt University Medical Center, New York University, University of Cincinnati, Synchronyx, LLC
Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis
07/25
07/25
MONITOR, NCT06750731: Study of Efficacy and Adherence to Subcutaneous Vs. Intravenous Vedolizumab in Patients with Inflammatory Bowel Disease Using a Novel Remote ing Intervention

Not yet recruiting
N/A
200
US
Tappt
Mercy Medical Center, Takeda
Inflammatory Bowel Disease (IBD), Crohn's Disease, Ulcerative Colitis
09/26
09/26

Download Options